1,313 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Argonautica Private Wealth Management Inc.

Argonautica Private Wealth Management Inc. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 1st quarter, Holdings Channel reports. The fund purchased 1,313 shares of the medical equipment provider’s stock, valued at approximately $650,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Hurley Capital LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Chilton Capital Management LLC boosted its position in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the period. Global Financial Private Client LLC lifted its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 38 shares during the period. Finally, Elite Financial Inc. purchased a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $26,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Royal Bank Of Canada boosted their price objective on Intuitive Surgical from $605.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday. Citigroup restated a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday. Robert W. Baird dropped their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Finally, Barclays decreased their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $592.05.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $501.95 on Thursday. The company has a market capitalization of $179.91 billion, a P/E ratio of 70.01, a P/E/G ratio of 5.42 and a beta of 1.64. The stock has a 50-day moving average price of $532.65 and a 200 day moving average price of $535.75. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.89% and a net margin of 28.51%. The business’s revenue was up 21.4% compared to the same quarter last year. During the same period last year, the company earned $1.78 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the business’s stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares in the company, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.